Growth Metrics

Amneal Pharmaceuticals (AMRX) Receivables Refunds (2018 - 2019)

Amneal Pharmaceuticals has reported Receivables Refunds over the past 2 years, most recently at $13.7 million for Q4 2019.

  • For Q4 2019, Receivables Refunds fell 53.62% year-over-year to $13.7 million; the TTM value through Dec 2019 reached $13.7 million, down 53.62%, while the annual FY2019 figure was $13.7 million, 53.62% down from the prior year.
  • Receivables Refunds for Q4 2019 was $13.7 million at Amneal Pharmaceuticals, down from $29.6 million in the prior quarter.
  • Over five years, Receivables Refunds peaked at $29.6 million in Q4 2018 and troughed at $13.7 million in Q4 2019.